Reference
US FDA. Teligent Pharma, Inc.'s Issues Voluntary Recall of Lidocaine HCl Topical Solution 4% (Lot #4218, Exp. 09/2022) Due to Super Potency. Internet Document : 30 Aug 2021. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teligent-pharma-incs-issues-voluntary-recall-lidocaine-hcl-topical-solution-4-lot-14218-exp-092022
Rights and permissions
About this article
Cite this article
Voluntary recall of Teligent Pharma's lidocaine topical solution. Reactions Weekly 1872, 5 (2021). https://doi.org/10.1007/s40278-021-01931-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-01931-y